Exonate to launch phase 2b trial of EXN407 for diabetic eye disease - PharmaTimes CLEAR-DE study to assess topical therapy for non-proliferative diabetic retinopathy

#drugdevelopment #Exonate #phase2btrial #EXN407 #diabeticeyedisease #CLEARDEstudy #topicaltherapy #nonproliferativediabeticretinopathy #NPDR #NPDRpatients #diabeticretinopathyprogression #Diabeticretinopathy #diabeticpopulation #VEGFexpression #mRNAsplicing
pharmatimes.com/news/exonate...

Ophthalmic Suspension Market Size, Growth Outlook 2035 Ophthalmic Suspension Market projected to grow at 3.41% CAGR, reaching USD 6.5 Billion by 2035, driving growth global trends, competitive industry analysis and outlook 2025-2035

👁️‍🗨️Precision in a drop! The #OphthalmicSuspension market rises with demand for targeted eye drug delivery systems.
#EyeHealth #Ophthalmology #TopicalTherapy

www.marketresearchfuture.com/reports/opht...